According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is -10,58 โฌ. In 2022 the company made an earnings per share (EPS) of -10,10 โฌ a decrease over its 2021 EPS that were of -7,55 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -10,86 โฌ | 7.57% |
2022 | -10,10 โฌ | 33.81% |
2021 | -7,55 โฌ | -15.17% |
2020 | -8,90 โฌ | 81.84% |
2019 | -4,89 โฌ | 40.52% |
2018 | -3,48 โฌ | -11.13% |
2017 | -3,92 โฌ | 48.1% |
2016 | -2,65 โฌ | 90.33% |
2015 | -1,39 โฌ | 78.25% |
2014 | -0,78 โฌ |